Largest biotechnology: biological products (no diagnostic substances) companies
Every US-listed biotechnology: biological products (no diagnostic substances) company we cover, 160 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$863.251 B
0.9% of all US-listed value
Companies
160
Ranked #23 of 152 industries
Average
$5.395 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | AmgenAMGN | $219.5B | $406.09 | -1.01% | United States |
| 2 | Gilead SciencesGILD | $187.7B | $151.37 | -0.85% | United States |
| 3 | ModernaMRNA | $72.7B | $182.11 | -0.25% | United States |
| 4 | Argenx SeARGX | $58.7B | $945.82 | -1.86% | Netherlands |
| 5 | Revolution MedicinesRVMD | $40.9B | $190.74 | -1.10% | United States |
| 6 | BiogenBIIB | $33.6B | $227.53 | +0.96% | United States |
| 7 | BioNTech SEBNTX | $24.7B | $98.46 | -2.39% | Germany |
| 8 | Neurocrine BiosciencesNBIX | $14.2B | $139.49 | -1.94% | United States |
| 9 | ExelixisEXEL | $14.1B | $56.73 | -2.44% | United States |
| 10 | Halozyme TherapeuticsHALO | $12.8B | $112.44 | -2.34% | United States |
| 11 | Bio-TechneTECH | $11.4B | $72.52 | -0.04% | United States |
| 12 | Twist BioscienceTWST | $10.5B | $158.50 | -3.71% | United States |
| 13 | Krystal BiotechKRYS | $10.1B | $341.75 | -2.60% | United States |
| 14 | Kymera TherapeuticsKYMR | $9.60B | $115.47 | -5.40% | United States |
| 15 | ImmunityBioIBRX | $9.15B | $8.63 | -7.10% | United States |
| 16 | RepligenRGEN | $9.03B | $184.53 | -1.19% | United States |
| 17 | QiagenQGEN | $9.01B | $43.71 | +0.05% | Netherlands |
| 18 | VaxcytePCVX | $8.41B | $56.50 | -4.28% | United States |
| 19 | ImmunovantIMVT | $7.13B | $34.54 | -7.38% | United States |
| 20 | CG OncologyCGON | $6.50B | $73.36 | -5.63% | United States |
| 21 | Scholar RockSRRK | $6.07B | $49.85 | -2.62% | United States |
| 22 | CRISPR TherapeuticsCRSP | $5.39B | $55.76 | -5.54% | Switzerland |
| 23 | Iovance BiotherapeuticsIOVA | $4.62B | $10.19 | -4.23% | United States |
| 24 | Adaptive BiotechnologiesADPT | $4.45B | $27.89 | -0.61% | United States |
| 25 | Relay TherapeuticsRLAY | $3.95B | $18.03 | -6.82% | United States |
| 26 | Tarsus PharmaceuticalsTARS | $3.48B | $74.29 | -3.62% | United States |
| 27 | Denali TherapeuticsDNLI | $3.27B | $20.46 | -5.28% | United States |
| 28 | Beam TherapeuticsBEAM | $2.52B | $24.37 | -6.02% | United States |
| 29 | AlvotechALVO | $2.27B | $5.81 | -0.51% | Luxembourg |
| 30 | Biocryst PharmaceuticalsBCRX | $2.19B | $8.57 | -2.39% | United States |
| 31 | Adma BiologicsADMA | $2.17B | $9.70 | -1.12% | United States |
| 32 | MesoblastMESO | $1.99B | $15.29 | -3.96% | Australia |
| 33 | VericelVCEL | $1.99B | $38.79 | -3.55% | United States |
| 34 | Kodiak SciencesKOD | $1.98B | $31.52 | -6.75% | United States |
| 35 | Recursion PharmaceuticalsRXRX | $1.98B | $3.70 | -8.64% | United States |
| 36 | Vir BiotechnologyVIR | $1.88B | $11.09 | -3.56% | United States |
| 37 | NovavaxNVAX | $1.74B | $10.55 | -2.58% | United States |
| 38 | Hemab TherapeuticsCOAG | $1.72B | $36.73 | -3.97% | United States |
| 39 | ImmunocoreIMCR | $1.62B | $31.54 | -2.71% | United Kingdom |
| 40 | Taysha Gene TherapiesTSHA | $1.60B | $4.91 | -4.84% | United States |
| 41 | Maze TherapeuticsMAZE | $1.56B | $28.09 | -1.02% | United States |
| 42 | Inhibrx BiosciencesINBX | $1.48B | $100.33 | -9.34% | United States |
| 43 | ImmaticsIMTX | $1.29B | $8.60 | -3.04% | Germany |
| 44 | Replimune GroupREPL | $1.22B | $12.96 | -3.79% | United States |
| 45 | Vor BiopharmaVOR | $1.15B | $19.37 | -11.96% | United States |
| 46 | MeiraGTxMGTX | $1.13B | $11.75 | -4.86% | United States |
| 47 | Cullinan TherapeuticsCGEM | $1.09B | $16.87 | -22.15% | United States |
| 48 | Monte Rosa TherapeuticsGLUE | $1.01B | $11.89 | -5.63% | United States |
| 49 | Odyssey TherapeuticsODTX | $997.7M | $20.76 | -11.05% | United States |
| 50 | SL ScienceSLBT | $930.9M | $1.66 | -1.19% | Taiwan |
| 51 | Sana BiotechnologySANA | $922.0M | $3.08 | -7.51% | United States |
| 52 | Candel TherapeuticsCADL | $863.9M | $11.29 | -4.73% | United States |
| 53 | Solid BiosciencesSLDB | $859.9M | $8.02 | -10.09% | United States |
| 54 | Attovia TherapeuticsATTO | $845.5M | $18.52 | -11.09% | United States |
| 55 | 4D Molecular TherapeuticsFDMT | $828.7M | $15.00 | -5.54% | United States |
| 56 | Electra TherapeuticsETRA | $795.3M | $12.67 | -6.97% | United States |
| 57 | DBV TechnologiesDBVT | $720.3M | $12.17 | -3.64% | France |
| 58 | Aura BiosciencesAURA | $624.3M | $6.02 | -6.67% | United States |
| 59 | Valneva SEVALN | $602.5M | $6.35 | -3.64% | France |
| 60 | Allogene TherapeuticsALLO | $577.0M | $1.67 | -2.34% | United States |
| 61 | Prime MedicinePRME | $567.7M | $3.13 | -11.58% | United States |
| 62 | Ginkgo BioworksDNA | $552.0M | $8.58 | -8.43% | United States |
| 63 | AgomAb TherapeuticsAGMB | $530.2M | $10.77 | -6.31% | Belgium |
| 64 | Autolus TherapeuticsAUTL | $519.0M | $1.95 | -3.94% | United Kingdom |
| 65 | Scribe TherapeuticsSCTX | $502.3M | $26.53 | -5.49% | United States |
| 66 | ProkidneyPROK | $498.8M | $1.65 | -9.84% | United States |
| 67 | RegenxbioRGNX | $495.1M | $7.50 | -7.98% | United States |
| 68 | Entera BioENTX | $488.5M | $2.81 | -5.71% | Israel |
| 69 | Tectonic TherapeuticTECX | $488.3M | $24.98 | -5.74% | United States |
| 70 | Eikon TherapeuticsEIKN | $440.4M | $8.13 | -9.46% | United States |
| 71 | Kyverna TherapeuticsKYTX | $437.2M | $7.07 | -5.86% | United States |
| 72 | Zura BioZURA | $414.9M | $4.33 | -3.99% | Cayman Islands |
| 73 | Editas MedicineEDIT | $413.1M | $2.69 | -7.88% | United States |
| 74 | AgenusAGEN | $379.4M | $8.40 | -3.45% | United States |
| 75 | C4 TherapeuticsCCCC | $378.9M | $3.08 | -6.95% | United States |
| 76 | Artiva BiotherapeuticsARTV | $377.4M | $7.72 | -4.57% | United States |
| 77 | Cabaletta BioCABA | $376.4M | $2.22 | -11.20% | United States |
| 78 | Fennec PharmaceuticalsFENC | $368.2M | $10.51 | -4.54% | United States |
| 79 | OcugenOCGN | $339.1M | $1.00 | -3.85% | United States |
| 80 | Century TherapeuticsIPSC | $318.7M | $1.76 | -6.88% | United States |
| 81 | SAB BiotherapeuticsSABS | $308.4M | $3.39 | -3.14% | United States |
| 82 | X4 PharmaceuticalsXFOR | $308.3M | $3.11 | -9.33% | United States |
| 83 | Inhibikase TherapeuticsIKT | $300.0M | $2.15 | -6.93% | United States |
| 84 | Fate TherapeuticsFATE | $291.2M | $2.43 | -5.81% | United States |
| 85 | Lexeo TherapeuticsLXEO | $288.8M | $3.52 | -13.51% | United States |
| 86 | Palisade BioPALI | $278.8M | $1.60 | -5.33% | United States |
| 87 | InvivydIVVD | $272.1M | $0.92 | -4.24% | United States |
| 88 | Sutro BiopharmaSTRO | $260.8M | $15.73 | -2.48% | United States |
| 89 | Lineage Cell TherapeuticsLCTX | $242.0M | $0.96 | -8.01% | United States |
| 90 | Protalix BioTherapeuticsPLX | $225.6M | $2.80 | -1.41% | Israel |
| 91 | AlectorALEC | $225.5M | $2.02 | +0.50% | United States |
| 92 | CompugenCGEN | $221.3M | $2.34 | -6.02% | Israel |
| 93 | Anavex Life SciencesAVXL | $217.8M | $2.35 | -4.86% | United States |
| 94 | Cardiol TherapeuticsCRDL | $213.6M | $1.77 | -6.35% | Canada |
| 95 | Compass TherapeuticsCMPX | $210.7M | $1.17 | -5.64% | United States |
| 96 | Protara TherapeuticsTARA | $209.2M | $3.54 | -3.80% | United States |
| 97 | Innate PharmaIPHA | $196.6M | $1.76 | -2.22% | France |
| 98 | Coherus OncologyCHRS | $194.7M | $1.26 | -3.08% | United States |
| 99 | SurrozenSRZN | $189.9M | $16.16 | -8.18% | United States |
| 100 | Voyager TherapeuticsVYGR | $176.8M | $2.87 | -8.60% | United States |
Showing the largest 100 of 160 companies. One row per company, with secondary share classes folded into their primary listing. Updated 24 Sept 2026.
Sectors biotechnology: biological products (no diagnostic substances) companies sit in
Other industries
Semiconductors 101Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 234Computer Manufacturing 10Biotechnology: Pharmaceutical Preparations 500Major Banks 246Industrial Machinery/Components 211Catalog/Specialty Distribution 31Business Services 93Commercial Banks 35Auto Manufacturing 29Integrated oil Companies 18Investment Bankers/Brokers/Service 68Oil & Gas Production 116Real Estate Investment Trusts 177Department/Specialty Retail Stores 14Telecommunications Equipment 82Electronic Components 21Beverages (Production/Distribution) 36Finance: Consumer Services 162Electric Utilities: Central 60Consumer Electronics/Appliances 23Natural Gas Distribution 29Medical Specialities 44All industries โ
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.